Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Preferred Shares (2016 - 2018)

Lisata Therapeutics filings provide 9 years of Preferred Shares readings, the most recent being $100.0 for Q3 2018.

  • For the quarter ending Q3 2018, Preferred Shares changed 0.0% year-over-year to $100.0, compared with a TTM value of $100.0 through Sep 2018, changed 0.0%, and an annual FY2016 reading of $100.0, changed 0.0% over the prior year.
  • Preferred Shares hit $100.0 in Q3 2018 for Lisata Therapeutics, roughly flat from $100.0 in the prior quarter.
  • The five-year high for Preferred Shares was $100.0 in Q1 2014, with the low at $100.0 in Q1 2014.
  • Median Preferred Shares over the past 5 years was $100.0 (2014), compared with a mean of $100.0.
  • The largest YoY upside for Preferred Shares was 0.0% in 2014 against a maximum downside of 0.0% in 2014.
  • Year by year, Preferred Shares stood at $100.0 in 2014, then changed by 0.0% to $100.0 in 2015, then changed by 0.0% to $100.0 in 2016, then changed by 0.0% to $100.0 in 2017, then changed by 0.0% to $100.0 in 2018.
  • According to Business Quant data, Preferred Shares over the past three periods came in at $100.0, $100.0, and $100.0 for Q3 2018, Q2 2018, and Q1 2018 respectively.